Combined treatment with L-carnitine and nicotinamide riboside attenuates obesity and hepatic steatosis and reverses high-fat dietinduced disease pathways in the liver

Kanita Salic, E. Gart, Lars Verschuren, Kari E. Wong, Ivana Bobeldijk-Pastorova, P.Y. Wielinga, Robert Kleemann

Research output: Contribution to conferencePosterAcademic

Original languageEnglish
Publication statusPublished - 15 Oct 2019
EventFENS 2019: Malnutrition in an Obese World-European Perspective - Dublin, Ireland
Duration: 15 Oct 201918 Oct 2019

Conference

ConferenceFENS 2019: Malnutrition in an Obese World-European Perspective
CountryIreland
CityDublin
Period15/10/1918/10/19

Cite this

Salic, K., Gart, E., Verschuren, L., Wong, K. E., Bobeldijk-Pastorova, I., Wielinga, P. Y., & Kleemann, R. (2019). Combined treatment with L-carnitine and nicotinamide riboside attenuates obesity and hepatic steatosis and reverses high-fat dietinduced disease pathways in the liver. Poster session presented at FENS 2019: Malnutrition in an Obese World-European Perspective, Dublin, Ireland.